Specific miRNAs in Sepsis and Nephrotoxic Antibiotic Treatment

CompletedOBSERVATIONAL
Enrollment

53

Participants

Timeline

Start Date

May 2, 2019

Primary Completion Date

June 30, 2021

Study Completion Date

December 1, 2022

Conditions
SepsisSeptic ShockAcute Kidney Injury
Interventions
DIAGNOSTIC_TEST

Blood-specific miRNA levels

Blood-specific miRNA levels associated with renal tubular damage change in patients treated with vancomycin or gentamicin compared to septic patients treated with other antimicrobials.

Trial Locations (1)

70852

University Hospital Ostrava, Ostrava

All Listed Sponsors
collaborator

Palacky University

OTHER

collaborator

University Hospital Olomouc

OTHER

collaborator

University of Ostrava

OTHER

collaborator

Technical University of Ostrava

UNKNOWN

lead

University Hospital Ostrava

OTHER

NCT04991376 - Specific miRNAs in Sepsis and Nephrotoxic Antibiotic Treatment | Biotech Hunter | Biotech Hunter